Tissue nerve growth factor concentrations in neuromuscular diseases

European Journal of Neurology

Volumn 5, Issue 5, 1998, Pages 487-490

  Stuerenburg, Hans Joerg ^a   Kunze, Klaus ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Amyotrophic lateral sclerosis; Muscle biopsy; Nerve growth factor; Neuromuscular diseases

Indexed keywords

NERVE GROWTH FACTOR;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DENERVATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; MUSCLE BIOPSY; MUSCULAR DYSTROPHY; MYOPATHY; NEUROMUSCULAR DISEASE; PRIORITY JOURNAL;

EID: 0031706422     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1331.1998.550487.x     Document Type: Article

References (23)

1. Amano T, Yamakuni T, Okabe N, Sakimura K, Takahashi Y (1991). Production of nerve growth factor in rat skeletal muscle. Neurosci Lett 132:5-7.
2. Eckenstein F (1988). Transient expression of NGF-receptor-like immunoreactivity in postnatal rat brain and spinal cord. Brain Res 446:149-154.
3. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis (1994). J Neurol Sci 124(suppl):96-107.
4. Faradji V, Sotelo J (1990). Low serum levels of nerve growth factor in diabetic neuropathy. Acta Neurol Scand 81:402-406.
5. Fernyhough P, Carrington AC, Tomlinson DR (1993). Reduced nerve growth factor mRNA in skin of diabetic rats: effect of insulin. Br J Pharmacol 107:462.
6. Funakoshi H, Frisen J, Barbany G, Timmusk T, Zachrisoon O, Verge VM, Persson H (1993). Differential expression of mRNAs for neurotrophins and their receptors after axotomy of the sciatic nerve. J Cell Biol 123:455-465.
7. Hanaoka Y, Ohi T, Furakawa Y, Hayashi K, Matsukura S (1994). The therapeutic effects of 4methylcatechol, a stimulator of endogenous nerve growth factor synthesis, on experimental diabetic neuropathy in rats. J Neurol Sci 122:28-32.
8. Hassakhani A, Steinhelper ME, Soonpaa MH, Katz EB, Taylor DA, Andrade-Rozental A, et al. (1995). Overexpression of NGF within the heart of transgenic mice causes hyperinnervation, cardiac enlargement and hyperplasia of ectopic cells. Dev Biol 169:309-321.
9. Hellweg F, Hartung HD (1990). Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus; a possible role for NGF in the pathogenesis of diabetic neuropathy. J Neurosci Res 26: 258-267.
10. Korsching S, Thoenen H (1987). Two-side enzyme immunoassay for nerve growth factor. Meth Enzymol 147:167-185.
11. Läkfors L, Ebendal T (1987). Highly sensitive enzyme immunoassay for β-nerve growth factor. J Immunol Meth 97:410-47.
12. Levi-Montalcini R, Angeletti PU (1968). Nerve growth factor Physiol Rev 48:534-569.
13. Levi-Montalcini R (1987). The nerve growth factor 35 years later. Science 237:1154-1162.
14. Lorigados L, Söderström S, Ebendal T (1992). Two-site enzyme immunoassay for β-NGF applied to human patient sera. J Neurosci Res 32:329-339.
15. Naeher-Noe M, Gnahn H, Grundler A, Klinglhofer J, Weindl A, Conrad, B (1993). Determination of nerve growth factor concentrations in human samples by two-site immunoenzymometric assay and bioassay. Eur J Clin Chem Clin Biochem 31:375-389.
16. Sagot Y, Rosse T, Vejsada R, Perrelet D, Kato AC (1998). Differential effects of neurotrophic factors on motoneuron retrograde labeling in a murine model of motoneuron disease. J Neurol Sci 18:1132-1141.
17. Sango K, Verdes JM, Hikawa N, Horie H, Tanaka S, Inoue S, et al. (1994). Nerve growth factor restores depletions of calcitonin gene-related peptide and substance P in sensory neurons from diabetic mice in vitro. J Neurol Sci 126:1-5.
18. Söderström S, Hallböök F, Ibanez CF, Persson H, Ebendal T (1990). Recombinant human β-nerve growth factor (NGF): biological activity and properties in an enzyme immunoassay. J Neurosci Res 27:665-677.
19. Stuerenburg HJ, Kunze K (1998). Tissue concentrations of nerve growth factor in aging rat heart and skeletal muscle. Muscle Nerve 21:404-406.
20. Thoenen H, Barde Y-A (1980). Physiology of nerve growth factor. Physiol Rev 60:1284-1335.
21. Thomas PK (1994). Growth factors and diabetic neuropathy. Diabetic Med 11:732-739.
22. Vejsada R, Sagot Y, Kato, AC (1995). Quantitative comparison of the transient rescue effects of neurotrophic factors on axotomized motoneurons in vivo. Eur J Neurosci 7:108-115.
23. Weskamp G, Otten U (1987). An enzyme-linked immunoassay for nerve growth factor (NGF): a tool for studying regulatory mechanisms involved in NGF production in brain and in peripheral tissues. J Neurochem 48:1779-1786.